Transplanting unrelated donor cells. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy30

Antilymphocyte Serum Fetal Blood Allografts T-Lymphocytes Transplants Hematopoietic Stem Cells Blastocyst Spleen Cells, Cultured Bone Marrow Cells Fibroblasts Philadelphia Chromosome Killer Cells, Natural Oocytes Neutrophils Embryo, Mammalian Totipotent Stem Cells Fetus Stem Cells Lymphocytes Bone Marrow Morula Cell Line Spermatogonia Liver CD4-Positive T-Lymphocytes Y Chromosome CD8-Positive T-Lymphocytes Clone Cells Thymus Gland

Organisms17

Transplantation Chimera Chimera Mice, Inbred C57BL Radiation Chimera Cytomegalovirus Mice, Inbred BALB C Cattle Mice, Inbred Strains Animals, Genetically Modified Mice, Transgenic Enterococcus faecalis Swine Mice, Inbred C3H Sus scrofa Mice, Knockout Escherichia coli Rats, Inbred Lew

Diseases35

Graft vs Host Disease Hematologic Neoplasms Leukemia Recurrence Anemia, Aplastic Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia, Myelogenous, Chronic, BCR-ABL Positive Hematologic Diseases Acute Disease Myelodysplastic Syndromes Leukemia, Myeloid, Acute Histiocytosis, Non-Langerhans-Cell Severe Combined Immunodeficiency Infection Wiskott-Aldrich Syndrome Metabolism, Inborn Errors Fanconi Anemia Cytomegalovirus Infections Chronic Disease Leukemia, Myelomonocytic, Acute Anemia, Refractory, with Excess of Blasts Cadaver Leukemia, Myeloid Immunologic Deficiency Syndromes Genetic Diseases, Inborn Lymphoproliferative Disorders Hepatic Veno-Occlusive Disease Lymphoma Philadelphia Chromosome Opportunistic Infections Neoplasm, Residual Lymphoma, Non-Hodgkin Neoplasm Recurrence, Local Multiple Myeloma Brain Death

Chemicals and Drugs38

HLA Antigens Vidarabine Antilymphocyte Serum Myeloablative Agonists Immunosuppressive Agents Busulfan HLA-DP beta-Chains HLA-DP Antigens HLA-A Antigens Cyclosporine HLA-B Antigens HLA-C Antigens Methotrexate Tacrolimus Cyclophosphamide HLA-DRB1 Chains Melphalan Mycophenolic Acid HLA-DR Antigens Antibodies, Neoplasm Methylprednisolone Receptors, KIR Antigens, CD34 Antibodies, Monoclonal Isoantigens Histocompatibility Antigens Class I Granulocyte Colony-Stimulating Factor Thiotepa HLA-DQ Antigens Green Fluorescent Proteins Cytarabine Isoantibodies Antineoplastic Agents H-2 Antigens Pheromones Antibodies, Monoclonal, Humanized DNA DNA, Bacterial

Analytical, Diagnostic and Therapeutic Techniques and Equipment83

Histocompatibility Testing Transplantation, Homologous Bone Marrow Transplantation Transplantation Conditioning Hematopoietic Stem Cell Transplantation Cord Blood Stem Cell Transplantation Cloning, Organism Whole-Body Irradiation Treatment Outcome Nuclear Transfer Techniques Peripheral Blood Stem Cell Transplantation Donor Selection Survival Analysis Disease-Free Survival Lymphocyte Depletion Survival Rate Retrospective Studies Stem Cell Transplantation Hemibody Irradiation Lymphocyte Transfusion Life Tables Remission Induction Actuarial Analysis Kidney Transplantation Immunosuppression Registries Transplantation, Isogeneic Follow-Up Studies Cause of Death Transplantation, Autologous Cell Transplantation Risk Factors Incidence Polymerase Chain Reaction Fetal Tissue Transplantation Leukocyte Transfusion Prognosis Salvage Therapy Research Embryo Creation Blood Cell Count Leukocyte Count Skin Transplantation Embryo Transfer Combined Modality Therapy Blood Preservation Liver Transplantation Prospective Studies Multivariate Analysis Proportional Hazards Models Hematopoietic Stem Cell Mobilization Kaplan-Meier Estimate Lymphocyte Count Cohort Studies Flow Cytometry Risk Platelet Count Embryo Culture Techniques Cell Separation Fatal Outcome Treatment Failure Pedigree Heart Transplantation Antineoplastic Combined Chemotherapy Protocols Probability Lymphocyte Culture Test, Mixed Tissue and Organ Harvesting Transplantation, Heterologous Brain Tissue Transplantation Transplantation, Heterotopic Drug Therapy, Combination Organ Transplantation Lymphocyte Activation Feasibility Studies Refrigeration Fertilization in Vitro Cell Fusion Graft Enhancement, Immunologic Adoptive Transfer Tissue Preservation Reverse Transcriptase Polymerase Chain Reaction Models, Animal In Situ Hybridization, Fluorescence DNA Mutational Analysis

Psychiatry and Psychology3

Siblings Nuclear Family Family

Phenomena and Processes48

Histocompatibility Graft Survival Graft Rejection Transplantation Immunology Time Factors Chimerism Graft vs Tumor Effect Conjugation, Genetic Graft vs Host Reaction Alleles Graft vs Leukemia Effect Haplotypes Radiation Chimera Genotype Blood Cell Count Major Histocompatibility Complex Leukocyte Count Hematopoiesis Host vs Graft Reaction Embryonic Development Base Sequence Philadelphia Chromosome Cell Differentiation Lymphocyte Count Polymorphism, Genetic Mutation Transplantation Tolerance Phenotype Risk Genes, MHC Class I Immune Tolerance Immunocompromised Host Platelet Count Nuclear Reprogramming Pregnancy Amino Acid Sequence Probability Plasmids Embryonic and Fetal Development Lymphocyte Activation Cell Survival Parthenogenesis Cell Fusion R Factors Ectogenesis Cell Movement Y Chromosome Cell Lineage

Anthropology, Education, Sociology and Social Phenomena3

Siblings Nuclear Family Family

Information Science9

Survival Rate Life Tables Registries Cause of Death Incidence Molecular Sequence Data Base Sequence Fatal Outcome Amino Acid Sequence

Named Groups6

Unrelated Donors Tissue Donors Blood Donors Living Donors Siblings Infant, Newborn

Health Care26

Treatment Outcome Donor Selection Survival Analysis Disease-Free Survival Survival Rate Retrospective Studies Tissue and Organ Procurement Directed Tissue Donation Life Tables Actuarial Analysis Registries Follow-Up Studies Cause of Death Risk Factors Incidence Prospective Studies Multivariate Analysis Proportional Hazards Models Kaplan-Meier Estimate Age Factors Cohort Studies Risk Fatal Outcome Treatment Failure Probability Feasibility Studies

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Unrelated Donors Tissue Donors Histocompatibility Testing Graft vs Host Disease Transplantation, Homologous Histocompatibility Bone Marrow Transplantation Transplantation Conditioning Hematopoietic Stem Cell Transplantation Hematologic Neoplasms Blood Donors Cord Blood Stem Cell Transplantation Living Donors Graft Survival HLA Antigens Transplantation Chimera Leukemia Cloning, Organism Recurrence Anemia, Aplastic Whole-Body Irradiation Treatment Outcome Nuclear Transfer Techniques Vidarabine Antilymphocyte Serum Peripheral Blood Stem Cell Transplantation Donor Selection Survival Analysis Myeloablative Agonists Siblings Disease-Free Survival Precursor Cell Lymphoblastic Leukemia-Lymphoma Immunosuppressive Agents Busulfan HLA-DP beta-Chains Graft Rejection Leukemia, Myelogenous, Chronic, BCR-ABL Positive Fetal Blood Lymphocyte Depletion Transplantation Immunology Survival Rate Retrospective Studies Stem Cell Transplantation Hematologic Diseases Acute Disease Myelodysplastic Syndromes HLA-DP Antigens Hemibody Irradiation Leukemia, Myeloid, Acute Tissue and Organ Procurement Allografts HLA-A Antigens Lymphocyte Transfusion Cyclosporine Directed Tissue Donation Life Tables Time Factors Remission Induction Actuarial Analysis Histiocytosis, Non-Langerhans-Cell T-Lymphocytes Severe Combined Immunodeficiency Chimerism HLA-B Antigens HLA-C Antigens Methotrexate Tacrolimus Kidney Transplantation Infection Immunosuppression Registries Transplants Graft vs Tumor Effect Transplantation, Isogeneic Follow-Up Studies Conjugation, Genetic Graft vs Host Reaction Wiskott-Aldrich Syndrome Cause of Death Chimera Cyclophosphamide HLA-DRB1 Chains Metabolism, Inborn Errors Transplantation, Autologous Cell Transplantation Alleles Graft vs Leukemia Effect Risk Factors Fanconi Anemia Cytomegalovirus Infections Hematopoietic Stem Cells Chronic Disease Melphalan Mycophenolic Acid Incidence Leukemia, Myelomonocytic, Acute HLA-DR Antigens Antibodies, Neoplasm Haplotypes Anemia, Refractory, with Excess of Blasts

No FAQ available that match "transplanting unrelated donor cells"